default author photo

Michael A. Davies

University of Texas at Houston - Department of Melanoma Medical Oncology

Houston, TX

United States

SCHOLARLY PAPERS

2

DOWNLOADS

141

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity

Number of pages: 70 Posted: 19 Mar 2021
University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of General Internal Medicine, University of Texas at Houston - Department of Immunology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center - Department of Gastroenterology, Hepatology and Nutrition, University of Texas at Houston - Pharmacy Clinical Programs, University of Texas at Houston - Pharmacy Clinical Programs, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology and University of Texas at Houston - Department of Melanoma Medical Oncology
Downloads 93 (730,864)

Abstract:

Loading...

Immunity, Toxicity, Colitis, Arthritis, Immune checkpoint blockade, Interleukin-6, Melanoma, TC1/TC-17, Th1/Th17, EAE

2.

The Landscape of Gain and Loss of Function Mutations in Melanoma

Number of pages: 41 Posted: 31 Jul 2025
University of Pennsylvania, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, University of Pennsylvania, University of Pennsylvania - Tara Miller Melanoma Center, University of Pennsylvania - Tara Miller Melanoma Center, University of Pennsylvania, University of Pennsylvania - Division of Hematology/Oncology, University of Pennsylvania, University of Pennsylvania, University of Pennsylvania, University of Pennsylvania, Saint John’s Cancer Institute at Providence Saint John’s Health Center, Saint John’s Cancer Institute at Providence Saint John’s Health Center, Saint John’s Cancer Institute at Providence Saint John’s Health Center, University of Texas at Houston, University of Texas at Houston, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, Oregon Health and Science University - Division of Oncological Sciences, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Harvard University - Massachusetts General Hospital, Massachusetts General Hospital and Harvard Medical School - Center for Cancer Immunology, Oregon Health and Science University, Wistar Institute, Wistar Institute and Independent
Downloads 48 (1,097,529)

Abstract:

Loading...

Melanoma, Multi-omics, PDX models, Variant classification, Computational modeling